Publications by authors named "S Cailleres"

Claim this Profile
R
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study.
Alexis Talbot, Arthur Bobin, Léa Tabone, Jérôme Lambert, Catherine Boccaccio, Sylvie Cailleres

Haematologica· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Asthenia, weight loss in a 55 year-old woman].
C Stavris, L Chiche, C Charpin, P Dukan, C Doncarli

Rev Med Interne· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Events Induced by PD-1/PD-L1 Inhibitors: A Real-World Single-Centre Experience with a Management-Based Approach.
Fabien Grimaud, Guillaume Penaranda, Chloé Stavris, Frédérique Retornaz, Véronique Brunel, Sylvie Cailleres

Ther Clin Risk Manag· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HHV8 and Kaposi's sarcoma: should we really give up protease inhibitors in all HIV-infected patients?
Patrick Philibert, Laurent Chiche, Sylvie Caillères, Julie Allemand, Stanislas Rebaudet

AIDS· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome.
Bruno Royer, Stéphane Minvielle, Momar Diouf, Murielle Roussel, Lionel Karlin, Sylvie Cailleres

J Clin Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis